Arizona Bioscience News: Anivax pursues chicken vaccine; Mayo to add proton therapy; Venture funding grows

August 6, 2015

By Amy Pitney

jobsUA spinoff Anivax seeks chicken vaccine OK / Arizona Daily Star

A Tucson startup spun off from University of Arizona technology is seeking approval from the U.S. Department of Agriculture to make and sell a vaccine to combat a common bacterial infection in chickens that can harm humans.

Coconino Voices: STEM City more than an acronym / Arizona Daily Sun (Op-ed)

This month marks the beginning of Flagstaff’s fourth year as STEM City, the vision of a group of local business, education, and government leaders who came together to expand on Flagstaff’s recognized strength in the science, technology, engineering, and math arena.

TGen developing affordable test to spot Lyme disease / Arizona Republic

Focus On Lyme is a new initiative sponsored by the Leadership Children’s Foundation of Gilbert, which has donated $75,000 to the Translational Genomics Research Institute to support research into the development of a quick, affordable and accurate method of diagnosing Lyme disease.

Mayo Clinic Phoenix to get proton therapy facility / Post-Bulletin

Next March, Mayo Clinic’s Phoenix campus will have a proton therapy facility that mirrors the one at Mayo’s Rochester site, giving local and regional patients a closer option for the burgeoning cancer treatment.

Venture capital deals surge in Arizona but still trail U.S. leaders / Arizona Republic

Venture capitalists invested $59 million in Arizona companies from April to June, nearly double the first-quarter tally but less than 1 percent of national funding.